Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
WuXi PharmaTech received ISO 14001 certification for its...
Chongqing Zhifei Biological Products will IPO on...
WuXi PharmaTech announced its new Suzhou toxicology...
Eddingpharm Inc. closed a $24 million Series B financing...
Pfizer announced that its new R&D center in Wuhan is up...
WuXi PharmaTech reported impressive Q3 results, showing...
“In 2010, venture capital investment in China life...
Charles River Labs intends to sell its Shanghai...
Bristol-Myers Squibb announced a strategic partnership...
Shanghai Pharma scheduled its upcoming $1.2 billion Hong...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
